Literature DB >> 32166679

Epstein-Barr Virus EA-IgA, VCA-IgA, and EBVNA-IgG Antibodies in a Population of Wuhan, China.

Zhen-Gang Tang1, Hui-Hui Li2, Yun-Cheng Li1, Mei-Xia Lv3, Xin Xu2, Jun-Chao Zeng2, Wei-Jia Kong4, Rui Yang5.   

Abstract

The study investigated the distribution of Epstein-Barr virus (EBV) EA-IgA, VCA-IgA, and EBVNA-IgG antibodies in a local population of Wuhan, China. Chemiluminescence immunoassay (CLIA) was used to detect EBV EA-IgA, VCA-IgA, and EBVNA-IgG antibodies in 972 subjects undergoing physical examination in Wuhan, and the results were analyzed. The detection rate of EBV was positively correlated with age. In the 972 cases, there was significant difference between different genders in the positive rate of VCA-IgA and EBVNA-IgG. Moreover, the positive rate of VCA-IgA and EBVNA-IgG was higher in men ≥ 60 years old than in those < 60 but no significant differences were found in three antibodies among various age groups. Our results suggested that the EBV infection should be intensively monitored in elderly people in Wuhan.

Entities:  

Keywords:  Epstein-Barr virus; antibody; nasopharyngeal carcinoma; physical examination

Mesh:

Substances:

Year:  2020        PMID: 32166679     DOI: 10.1007/s11596-020-2160-x

Source DB:  PubMed          Journal:  Curr Med Sci        ISSN: 2523-899X


  8 in total

1.  Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum.

Authors:  Wei-min Cheng; Kwok Hung Chan; Hong-lin Chen; Rui-xian Luo; S Park Ng; Winsie Luk; Bo-jian Zheng; Ming-fang Ji; Jin-sheng Liang; Jonathan S T Sham; De-Kun Wang; Yong-sheng Zong; Mun Hon Ng
Journal:  Int J Cancer       Date:  2002-02-01       Impact factor: 7.396

Review 2.  Overview and problematic standpoints of severe chronic active Epstein-Barr virus infection syndrome.

Authors:  Motohiko Okano
Journal:  Crit Rev Oncol Hematol       Date:  2002-12       Impact factor: 6.312

Review 3.  Nasopharyngeal carcinoma.

Authors:  William I Wei; Jonathan S T Sham
Journal:  Lancet       Date:  2005 Jun 11-17       Impact factor: 79.321

Review 4.  Epstein-Barr virus serology in early detection and screening of nasopharyngeal carcinoma.

Authors:  Mun-Hon Ng; Kwok-Hung Chan; Sze-Park Ng; Yong-Sheng Zong
Journal:  Ai Zheng       Date:  2006-02

Review 5.  Epstein-Barr virus and cancer.

Authors:  Matthew P Thompson; Razelle Kurzrock
Journal:  Clin Cancer Res       Date:  2004-02-01       Impact factor: 12.531

6.  Salivary gland and nasopharyngeal cancers in individuals with acquired immunodeficiency syndrome in United States.

Authors:  Fatma M Shebl; Kishor Bhatia; Eric A Engels
Journal:  Int J Cancer       Date:  2010-05-15       Impact factor: 7.396

7.  Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma.

Authors:  Zhengrong Wu; Gang Li; Lirong Wu; Desheng Weng; Xiangping Li; Kaitai Yao
Journal:  BMC Cancer       Date:  2009-09-06       Impact factor: 4.430

Review 8.  Epstein-Barr virus in systemic autoimmune diseases.

Authors:  Anette Holck Draborg; Karen Duus; Gunnar Houen
Journal:  Clin Dev Immunol       Date:  2013-08-24
  8 in total
  1 in total

1.  Efficacy of Chemiluminescence Immunoassays on VCA-IgA and EBNA1-IgA Antibodies of Epstein-Barr Virus in Diagnosing Nasopharyngeal Carcinoma.

Authors:  Xia Yu; Fugui Li; Weimin Cheng; Biaohua Wu; Huiyun Fang; Fuzhen Xia; Yijun Gong; Wenjing Yu; Pu Liao; Youde Cao; Fenghua Yang; Hong Zhu; Jiang Li; Yajun Huang; Liying Gan; Lei Zhang; Yonggang Lou; Mingfang Ji
Journal:  J Cancer       Date:  2020-10-18       Impact factor: 4.207

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.